Paediatric Infection Diagnosis and Biomarker-Guided Reassessment

Paediatrics
Early and accurate diagnosis of infections in children is essential for timely treatment and prevention of complications. Clinical assessment combined with laboratory investigations, including complete blood counts, C-reactive protein (CRP), procalcitonin (PCT) and selected emerging biomarkers, can support infection detection and risk assessment. However, no single biomarker can reliably distinguish all bacterial and viral infections or replace clinical evaluation. Serial biomarker measurements, interpreted alongside clinical progress, microbiological findings and organ function, can help assess treatment response and guide antibiotic reassessment. Understanding biomarker kinetics, diagnostic limitations and antimicrobial stewardship principles is important for avoiding unnecessary antibiotic exposure while ensuring timely escalation or de-escalation of treatment. Please participate in the survey and share your opinion on paediatric infection diagnosis and biomarker-guided reassessment.
In your opinion, which biomarker is most useful for distinguishing bacterial from viral infections in children?
- Procalcitonin
- C-reactive protein
- White blood cell count
- Erythrocyte sedimentation rate
In a child with suspected infection who does not respond to initial management, what would you reassess?
- Initial diagnosis
- Infection source
- Antibiotic sensitivity
- Biomarker trends